Kidney News and Research

RSS

FDA warns against use of red yeast rice products promoted as high cholesterol treatment

The U.S. Food and Drug Administration is warning consumers not to buy or eat three red yeast rice products promoted and sold on Web sites.

12 Aug 2007

Sex hormones play a significant role in the development of diabetic kidney disease

Women have a "female advantage" when it comes to chronic kidney disease. When compared to men, they have fewer and less severe episodes of this disorder throughout most of their lives.

11 Aug 2007

FGFR4 gene plays a complex role in obesity, fatty liver and diabetes

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston have found that a gene in the liver and elsewhere in the body, when inhibited or increased, affects fatty liver and diabetes but does not alleviate both diseases at once.

11 Aug 2007

Gender differences in renal and other genes contributing to blood pressure

Many common diseases exhibit gender bias and gender differences have been observed in the development of high blood pressure (hypertension) and heart (cardiovascular) disease.

9 Aug 2007

Estrogen deficiency may trigger the development of high blood pressure and obesity in aged females

At menopause, women lose hormone protection against heart (cardiovascular) and kidney (renal) diseases, and are likely to become obese. A research team has tested the idea that estrogen deficiency in aged females may trigger the development of high blood pressure and obesity.

9 Aug 2007

Obesity linked to hyperparathyroidism in chronic kidney disease

For patients with chronic kidney disease (CKD), the risk of elevated levels of parathyroid hormone (PTH), or hyperparathyroidism a significant complication that increases the risk of cardiovascular problems and death increases along with body weight, reports a study in the September Clinical Journal of the American Society of Nephrology.

9 Aug 2007

Sex and gender in cardiovascular-renal physiology and pathophysiology

Gender influences the prevalence and progression rate of many renal diseases, such as polycystic kidney disease (PKD).

9 Aug 2007

Lack of sleep leads to increased urinary output and more salt in urine

Our body's production of urine follows a circadian rhythm. During the day, we experience greater urinary frequency; at night, urine production declines, enabling us to get uninterrupted sleep.

9 Aug 2007

Steep rises in cancers linked to excessive sun exposure, alcohol, smoking and obesity

Rates of melanoma, the most dangerous form of skin cancer, have risen by over 40 per cent in the past decade, making it the fastest rising cancer in the UK. Incidence of mouth, womb, and kidney cancers has also shown rapid increases in the last 10 years.

8 Aug 2007

Vitamin B1 deficiency key to vascular problems for diabetic patients

Researchers at Warwick Medical School, University of Warwick, have discovered that deficiency of thiamine - vitamin B1 - may be key to a range of vascular problems for people with diabetes.

8 Aug 2007

High-intensity focused ultrasound may alerts the immune system to cancer

An intense form of ultrasound that shakes a tumor until its cells start to leak can trigger an alarm that enlists immune defenses against the cancerous invasion, according to a study led by researchers at Duke University's Pratt School of Engineering.

8 Aug 2007

Potential biomarker to predict acute kidney injury earlier than current tests

Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown.

3 Aug 2007

Hip resurfacing may delay hip replacement

In the world of prosthetic hips, what was old is new again. A procedure known as hip resurfacing, once tried two to three decades ago, is experiencing a resurgence in the U.S., thanks to improved technology.

3 Aug 2007

CT-guided radiofrequency ablation effective in eradicating small malignant kidney tumors

A relatively new, minimally invasive treatment was 100 percent successful in eradicating small malignant kidney tumors in a study of more than 100 patients, report researchers from Wake Forest University Baptist Medical Center.

3 Aug 2007

Genta and Emisphere Technologies file investigational new drug exemption

Genta Inc. and Emisphere Technologies, Inc. have jointly announced the submission of an Investigational New Drug Exemption (IND) to the Endocrinologic and Metabolic Drugs Division of the U.S. Food and Drug Administration (FDA) for a new drug known as G4544.

2 Aug 2007

Reducing inflammation plays key role in type 1 diabetes therapy

Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.

1 Aug 2007

Xenomics issued European patent for Transrenal Nucleic Acid Technology for Prenatal Diagnostics

Xenomics, Inc. has announced the issuance of its first European patent "Methods for detection of nucleic acid sequences in urine", EP 1634966 A2 that covers use of its proprietary transrenal nucleic acid technology in the area of prenatal diagnostics and genetic testing.

1 Aug 2007

Insulin produced in genetically modified lettuce relieves diabetes in mice

Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the body's ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes, according to University of Central Florida biomedical researchers.

1 Aug 2007

Interferon alpha and sorafenib combined work better than either alone against kidney cancer

A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.

1 Aug 2007

Avandia too risky says expert

One of the members of the advisory panel set up to discuss the future of the diabetes pill Avandia says it should be removed from the market because it is too risky and offers no advantage over other alternatives.

30 Jul 2007